Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Takeda
Takeda
AstraZeneca
Alexandria University
Takeda
University of Maryland, Baltimore
Zhengzhou University
Seoul National University Hospital
Charite University, Berlin, Germany
Sanofi